2023 annual financial data
Cumberland Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -24.16%.
Operating income was -9,554,661 USD and net income was -6,279,320 USD.
Operating cash flow was 6,093,821 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 39,552,507 USD
- Operating income
- -9,554,661 USD
- Net income
- -6,279,320 USD
- Operating cash flow
- 6,093,821 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Cumberland Pharmaceuticals financial years